PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.90
+0.10 (0.23%)
Aug 3, 2026, 5:14 PM CET
PolyPeptide Group AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -21.17 | -19.56 | -51.44 | 7.77 | 47.26 |
Depreciation & Amortization | 38.07 | 32.71 | 30.47 | 26.06 | 20.68 |
Stock-Based Compensation | 2.02 | 1.2 | 0.84 | 1.16 | 1.21 |
Other Adjustments | 30.77 | 12.5 | 15.88 | 5.67 | 21.47 |
Change in Receivables | 18.76 | -5.01 | -29.89 | 18.9 | -11.75 |
Changes in Inventories | -11.1 | -16.97 | 15.51 | -33.13 | -17.67 |
Changes in Accounts Payable | 5.64 | 11.37 | 17.37 | 13.23 | 1.18 |
Changes in Accrued Expenses | 5.59 | -1.98 | 7.56 | -3.35 | 1.65 |
Changes in Income Taxes Payable | -3.76 | -1.96 | -0.76 | -7.98 | -11.4 |
Changes in Unearned Revenue | 27.42 | 89.9 | 38.84 | -18.63 | 11.49 |
Changes in Other Operating Activities | -14.72 | -12.81 | -7.89 | -4.24 | -6.77 |
Operating Cash Flow | 77.51 | 89.4 | 36.49 | 5.46 | 57.35 |
Operating Cash Flow Growth | -13.30% | 145.03% | 568.22% | -90.48% | 15.90% |
Capital Expenditures | -107.75 | -85.75 | -52.9 | -75.1 | -73.96 |
Sale of Property, Plant & Equipment | 0.59 | 0 | 0.01 | 0.01 | 0.12 |
Purchases of Intangible Assets | -1.15 | -1.22 | -3.84 | -3.67 | -3.75 |
Purchases of Investments | -3.39 | -2.49 | -2.79 | 0.32 | -3.26 |
Other Investing Activities | - | -1.56 | - | - | - |
Investing Cash Flow | -111.71 | -91.02 | -59.51 | -78.44 | -80.85 |
Short-Term Debt Issued | - | - | 95.17 | 0 | 25 |
Short-Term Debt Repaid | -10 | -10 | -55.17 | 0 | -25 |
Net Short-Term Debt Issued (Repaid) | -10 | -10 | 40 | 0 | 0 |
Long-Term Debt Issued | 50 | - | 49.09 | - | - |
Long-Term Debt Repaid | -0.77 | -10.7 | -0.62 | -0.57 | -38.73 |
Net Long-Term Debt Issued (Repaid) | 49.23 | -10.7 | 48.47 | -0.57 | -38.73 |
Issuance of Common Stock | - | - | - | 0 | 182.14 |
Repurchase of Common Stock | -0.48 | - | - | -13.93 | -5.46 |
Net Common Stock Issued (Repurchased) | -0.48 | - | - | -13.93 | 176.68 |
Common Dividends Paid | - | - | - | -9.67 | 0 |
Other Financing Activities | -4.95 | -4.63 | -3.92 | -2.7 | -7.02 |
Financing Cash Flow | 33.79 | -25.32 | 84.55 | -26.87 | 130.93 |
Foreign Exchange Rate Adjustments | 6.72 | -0.49 | -3.34 | 1.07 | 11.66 |
Net Cash Flow | -0.41 | -26.94 | 61.52 | -99.84 | 107.44 |
Free Cash Flow | -30.24 | 3.65 | -16.41 | -69.64 | -16.61 |
Free Cash Flow Growth | - | - | - | - | - |
FCF Margin | -7.72% | 1.08% | -5.05% | -24.57% | -5.80% |
Free Cash Flow Per Share | -0.92 | 0.11 | -0.50 | -2.11 | -0.52 |
Levered Free Cash Flow | -42.57 | -25.75 | 85.23 | -95.93 | -66.27 |
Unlevered Free Cash Flow | -51.45 | 6.58 | 15.99 | -90.19 | -24.13 |